title: [Sermion in the treatment of patients with neurological diseases].
authors.forename: P A
authors.initials: PA
authors.lastname: Kovalenko
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Kolomoets
authors.forename: A D
authors.initials: AD
authors.lastname: Seropegin
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D006801:Humans; D009530:Nicergoline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013607:Tablets; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D013607:Tablets; D014665:Vasodilator Agents; D009530:Nicergoline